IGHE and asthma: Asthma control improved, allowing a reduction of budesonide/formoterol to 320/9 mcg/day (SCORAD - 52; DLQI - 13; ACQ-5 - 1.2; AEC 900 cells/μl; total IgE - 7,800 IU/ml) (see Figure 1).